Showing results (41-50 of 76) with videos related to

Sort By:
Pageof 8
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|April 17, 2013
Colon cancer-specific cytochrome P450 2W1 converts duocarmycin analogues into potent tumor cytotoxinsSandra Travica, Klaus Pors, Paul M Loadman, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|February 24, 2004
Comparative preclinical pharmacokinetic and metabolic studies of the combretastatin prodrugs combretastatin A4 phosphate and A1 phosphateIan G Kirwan, Paul M Loadman, David J Swaine, et al.
Cancer Chemotherapy and Pharmacology|October 11, 2020
Cyclooxygenase activity mediates colorectal cancer cell resistance to the omega-3 polyunsaturated fatty acid eicosapentaenoic acidMilene Volpato, Nicola Ingram, Sarah L Perry, et al.
Biochemical Pharmacology|October 23, 2004
Pharmacological and biological evaluation of a series of substituted 1,4-naphthoquinone bioreductive drugsRoger M Phillips, Mohammed Jaffar, Derek J Maitland, et al.
Pharmaceutics|March 26, 2022
A Single Short 'Tone Burst' Results in Optimal Drug Delivery to Tumours Using Ultrasound-Triggered Therapeutic MicrobubblesNicola Ingram, Laura E McVeigh, Radwa H Abou-Saleh, et al.
Bioorganic & Medicinal Chemistry|May 1, 2021
Probing cytochrome P450 (CYP) bioactivation with chloromethylindoline bioprecursors derived from the duocarmycin family of compoundsNatalia Ortuzar, Kersti Karu, Daniela Presa, et al.
Neoplasia (New York, N.Y.)|February 22, 2005
MMP-10 is overexpressed, proteolytically active, and a potential target for therapeutic intervention in human lung carcinomasJason H Gill, Ian G Kirwan, Jill M Seargent, et al.
Pageof 8